An apparatus, comprising; a main lead assembly having a proximal portion adapted for connection to a device and a distal portion adapted for placement in a coronary sinus of a human heart, the distal portion terminating in a distal end for placement proximal a left ventricle; a left ventricular electrode located at the distal end of the main lead assembly and adapted to placed in a coronary vein proximal to the left ventricle,; a right ventricular electrode located at the distal end of a second lead. the second lead sized for placement through a right atrium and in a right ventricle, and a fat pad electrode disposed along the main lead assembly at a fixed distance from the distal end of the main lead assembly and the left ventricular electrode, wherein the main lead assembly is sized such that the distance between the fat pad electrode and the distal end of the main lead assembly including the left ventricular electrode is such that the fat pad electrode is located in the coronary sinus proximal to parasympathetic ganglia located in a fat pad bounded by an inferior vena cava and a left atrium and the left ventricular electrode is located in the coronary vein proximal the left ventricle when the main lead assembly is implanted in the coronary sinus; and an implantable device connected to the proximal portion of the main lead assembly and to the second lead, the implantable device configured to use the left ventricular electrode and the right ventricular electrode to deliver cardiac resynchronization therapy stimulation pulses and to use the fat pad electrode to deliver a train of neural stimulation pulses in conjunction with the cardiac resynchronization therapy stimulation pulses to reduce ventricular wall stress. a main lead assembly having a proximal portion adapted for connection to a device and a distal portion adapted for placement in a coronary sinus of a human heart, the distal portion terminating in a distal end for placement proximal a left ventricle; a left ventricular electrode located at the distal end of the main lead assembly and adapted to placed in a coronary vein proximal to the left ventricle,; a right ventricular electrode located at the distal end of a second lead. the second lead sized for placement through a right atrium and in a right ventricle, and a fat pad electrode disposed along the main lead assembly at a fixed distance from the distal end of the main lead assembly and the left ventricular electrode, wherein the main lead assembly is sized such that the distance between the fat pad electrode and the distal end of the main lead assembly including the left ventricular electrode is such that the fat pad electrode is located in the coronary sinus proximal to parasympathetic ganglia located in a fat pad bounded by an inferior vena cava and a left atrium and the left ventricular electrode is located in the coronary vein proximal the left ventricle when the main lead assembly is implanted in the coronary sinus; and an implantable device connected to the proximal portion of the main lead assembly and to the second lead, the implantable device configured to use the left ventricular electrode and the right ventricular electrode to deliver cardiac resynchronization therapy stimulation pulses and to use the fat pad electrode to deliver a train of neural stimulation pulses in conjunction with the cardiac resynchronization therapy stimulation pulses to reduce ventricular wall stress.